Medicare's AI Approval Pilot Coincides With a Steep Drop in Services

Medicare is testing whether artificial intelligence can speed up one of the most contested parts of the program: prior authorization, the step where a provider must get advance approval before a service is covered. The stated goal is to use AI to flag care that looks wasteful or inappropriate and cut spending on it.

The early results are drawing attention. According to the source report, medical services dropped by a large margin soon after the AI review began. The summary does not break down which procedures declined or by how much, so the size of the drop should be read as the report's characterization rather than a settled figure.

That gap matters to investors and policymakers alike. Medicare decisions ripple through hospitals, physician groups, device makers and insurers that serve older patients. If an automated review system can reduce volume quickly, providers in the affected service lines may feel it first in their revenue, and companies that sell prior-authorization software could take on a larger role in federal programs.

The tension is clear. Supporters of tighter review argue that some services are performed more often than clinically justified. Critics, including many physicians, worry that automated decisions could delay or deny care patients need, and that faster review does not guarantee fair review. Whether the decline reflects fewer unnecessary procedures or fewer necessary ones will likely decide how the policy is judged.

Expect more detail as the test continues. Official program data, reaction from provider groups, and any changes to how AI-assisted denials are checked by human clinicians will show whether the drop was a sign of waste removed or access lost.